Filing Details

Accession Number:
0001209191-17-023720
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-30 18:34:37
Reporting Period:
2017-03-28
Filing Date:
2017-03-30
Accepted Time:
2017-03-30 18:34:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412067 Cascadian Therapeutics Inc. CASC Services-Commercial Physical & Biological Research (8731) 260868560
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1506217 A. Gwen Fyfe C/o Cascadian Therapeutics, Inc.
2601 Fourth Ave., Suite 500
Seattle WA 98121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-28 1,666 $4.12 3,332 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct